🇺🇸 FDA
Patent

US 8163794

Crystalline form of a 3-phenoxymethylpyrrolidine compound

granted A61KA61K31/40A61K45/06

Quick answer

US patent 8163794 (Crystalline form of a 3-phenoxymethylpyrrolidine compound) held by Theravance, Inc. expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P13/00